Ausgabe 3/2008
Inhalt (20 Artikel)
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up
Salomone Di Saverio, Fausto Catena, Donatella Santini, Luca Ansaloni, Tommaso Fogacci, Stefano Mignani, Antonio Leone, Filippo Gazzotti, Stefano Gagliardi, Angelo De Cataldis, Mario Taffurelli
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
Wei T. Yang, Huong T. Le-Petross, Homer Macapinlac, Selin Carkaci, Ana M. Gonzalez-Angulo, Shaheenah Dawood, Erika Resetkova, Gabriel N. Hortobagyi, Massimo Cristofanilli
Precancerous model of human breast epithelial cells induced by NNK for prevention
Nalin Siriwardhana, Shambhunath Choudhary, Hwa-Chain Robert Wang
Pre-administration of docetaxel protects against adriamycin-induced cardiotoxicity
Hiromi Sakaguchi, Ayumi Kodama, Mari Tomonari, Yukie Ando, Mayumi Tabuchi, Hideto To, Ryosuke Araki, Takashi Kitahara, Hitoshi Sasaki, Shigehiro Ohdo, Shun Higuchi
Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death
Elena P. Moiseeva, Raimond Heukers
Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer
Ander Urruticoechea, Helena Aguilar, Xavier Solé, Gabriel Capellà, Lesley-Ann Martin, Mitch Dowsett, Josep Ramon Germà-Lluch
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75
Teresa Puig, Alejandro Vázquez-Martín, Joana Relat, Jordi Pétriz, Javier A. Menéndez, Rut Porta, Gemma Casals, Pedro F. Marrero, Diego Haro, Joan Brunet, Ramon Colomer
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
Keun Seok Lee, Jungsil Ro, Byung-Ho Nam, Eun Sook Lee, Youngmee Kwon, Hye Soo Kwon, Ki Wook Chung, Han Sung Kang, Eun A Kim, Seok Won Kim, Kyung Hwan Shin, Seok-Ki Kim
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen
Mario Campone, Loïc Campion, Henry Roché, Wilfried Gouraud, Catherine Charbonnel, Florence Magrangeas, Stéphane Minvielle, Jean Genève, Anne-Laure Martin, Régis Bataille, Pascal Jézéquel
Sentinel node biopsy in patients with multiple breast cancer
Hee Jeong Kim, Jung Sun Lee, Eun Hwa Park, Sung Lim Choi, Woo Sung Lim, Mi Ae Chang, Bo Kyong Ku, Gyong Yup Gong, Byung Ho Son, Sei Hyun Ahn
BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy
Kathryn J. Schlich-Bakker, Margreet G. E. M. Ausems, Maria Schipper, Herman F. J. ten Kroode, Carla C. Wárlám-Rodenhuis, Jan van den Bout
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women
David Cella, Stephanie R. Land, Chih-Hung Chang, Richard Day, Joseph P. Costantino, Norman Wolmark, Patricia A. Ganz
SSRI use and breast cancer risk by hormone receptor status
Patricia F. Coogan, Brian L. Strom, Lynn Rosenberg
NSAID use and breast cancer risk in the VITAL cohort
Ann Ready, Christine M. Velicer, Anne McTiernan, Emily White
Parity and disparity in first course treatment of invasive breast cancer
Mary Jo Lund, Otis P. Brawley, Kevin C. Ward, John L. Young, Sheryl S. G. Gabram, J. William Eley
The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data
Takeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, Yasuo Ohashi, Kiichiro Tsutani
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
R. A. Nout, W. E. Fiets, H. Struikmans, F. R. Rosendaal, H. Putter, J. W. R. Nortier
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Marilyn L. Kwan, Laurel A. Habel, E. Dawn Flick, Charles P. Quesenberry, Bette Caan
Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques
Michal Konecny, Katarina Zavodna, Vladimira Vranova, Miriam Vizvaryova, Eva Weismanova, Iveta Mlkva, Petr Kuglik, Juraj Kausitz, Zdena Bartosova